grey market semaglutide Rybelsus (Oral Semaglutide) Novo, Lilly poised to overcome
Description
Discovery of the once-weekly GLP-1 analogue semaglutide
Your car hits 120 degrees in a parking lot
Together, they attack weight and metabolic dysfunction from multiple angles simultaneously
As of November 2025, nearly 80% (77.8%) of all Microdose GLP-1Rx users stayed engaged with the Noom app for 4 or more weeks, and D30 engagement for our December cohort was over 40% (43.6%), 1 which is at least 10 times higher than average health, medical, and fitness app retention
Your body is adjusting to the medication, and if you have recently increased your dose, the effect compounds
